WallStreetZenWallStreetZen

NASDAQ: BFRI
Biofrontera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BFRI stock forecasts and price targets.

Forecast return on equity

Is BFRI forecast to generate an efficient return?

Company
N/A
Industry
286.15%
Market
228.88%

Forecast return on assets

Is BFRI forecast to generate an efficient return on assets?

Company
N/A
Industry
157.64%

BFRI earnings per share forecast

What is BFRI's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.54
Avg 2 year Forecast
-$0.13
Avg 3 year Forecast
$0.12

BFRI revenue forecast

What is BFRI's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$40.9M+10.17%
Avg 2 year Forecast
$45.4M+22.25%
Avg 3 year Forecast
$53.2M+43.02%
BFRI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BFRI revenue growth forecast

How is BFRI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
12.67%
Industry
132.79%
Market
25.69%
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BFRI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
BFRI$0.83N/AN/A
CPHI$1.66N/AN/A
KALA$0.96$32.67+3,288.69%Buy
FLGC$10.45N/AN/A
GELS$1.10N/AN/A
View Top Pharmaceutical Stocks

Biofrontera Stock Forecast FAQ

What is BFRI's earnings growth forecast for 2025-2027?

(NASDAQ: BFRI) Biofrontera's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 365.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Biofrontera's earnings in 2025 is -$17,572,000.On average, 4 Wall Street analysts forecast BFRI's earnings for 2025 to be -$17,940,747, with the lowest BFRI earnings forecast at -$17,237,188, and the highest BFRI earnings forecast at -$18,468,416. On average, 4 Wall Street analysts forecast BFRI's earnings for 2026 to be -$1,544,568, with the lowest BFRI earnings forecast at -$2,625,532, and the highest BFRI earnings forecast at -$366,922.

In 2027, BFRI is forecast to generate $1,425,755 in earnings, with the lowest earnings forecast at $1,369,843 and the highest earnings forecast at $1,467,689.

If you're new to stock investing, here's how to buy Biofrontera stock.

What is BFRI's revenue growth forecast for 2025-2027?

(NASDAQ: BFRI) Biofrontera's forecast annual revenue growth rate of 12.67% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 132.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.

Biofrontera's revenue in 2025 is $37,165,000.On average, 4 Wall Street analysts forecast BFRI's revenue for 2025 to be $476,917,289, with the lowest BFRI revenue forecast at $452,048,119, and the highest BFRI revenue forecast at $497,558,117. On average, 4 Wall Street analysts forecast BFRI's revenue for 2026 to be $529,218,259, with the lowest BFRI revenue forecast at $503,417,223, and the highest BFRI revenue forecast at $550,196,889.

In 2027, BFRI is forecast to generate $619,166,609 in revenue, with the lowest revenue forecast at $594,891,504 and the highest revenue forecast at $637,384,586.

What is BFRI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BFRI) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 157.64%.

What is BFRI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BFRI) Biofrontera's current Earnings Per Share (EPS) is -$1.49. On average, analysts forecast that BFRI's EPS will be -$1.54 for 2025, with the lowest EPS forecast at -$1.48, and the highest EPS forecast at -$1.59. On average, analysts forecast that BFRI's EPS will be -$0.13 for 2026, with the lowest EPS forecast at -$0.23, and the highest EPS forecast at -$0.03. In 2027, BFRI's EPS is forecast to hit $0.12 (min: $0.12, max: $0.13).

What is BFRI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BFRI) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.